Tuesday, 17 November 2026 Every SEC filing alert, by company
ALFA USA Filings Every alert, straight from SEC EDGAR
News

BriaCell Therapeutics Corp.

NASDAQ: BCTX · Life Sciences · 1 alert · CIK 1610820

Share price
$3.30Close, Nov 16
Market cap
$28.8M
Shares outstanding
8.73MLatest SEC cover page
Sector
Life Sciences
Industry
Pharmaceutical PreparationsSIC 2834

Today's reference numbers: shares from the company's latest SEC cover page, price from the latest market close. Not a valuation or a recommendation. All BriaCell Therapeutics Corp. filings on SEC EDGAR ↗

4:43 PM ET 10-K
Financial Results

BriaCell Therapeutics FY 2026 Results: Net Loss of $34.9M, Loss Widens

BriaCell Therapeutics Corp. is a pre-revenue clinical-stage biotechnology company facing substantial competition and significant going concern risks. The company expects increased operating expenses as it advances its Phase 3 Bria-IMT™ and Phase 1/2 Bria-OTS™ clinical programs, while managing risks related to data security, key personnel retention, and its majority stake in BriaPro.

Key figure
Net loss $34.9M

Get Alerts

Get ALFA Finder alerts first

Real-time SEC filing alerts for US stocks are launching soon. Leave your details and we'll tell you the moment they go live.